Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
Biodesix
BDSX
$283M
| $248K | ﹤0.01% |
5,389
-513
| -9% | -$13.9K |
|
5152
CALL
Citizens Financial Group
CFG
$29.4B
| $248K | ﹤0.01% |
6,300
| – | – |
|
|
LNW
5153
DELISTED
Light & Wonder
LNW
| $248K | ﹤0.01% |
4,229
-30,881
| -88% | -$1.77M |
|
5154
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
| $247K | ﹤0.01% |
3,173
-11,186
| -78% | -$873K |
|
5155
Alaunos Therapeutics
TCRT
$4.06M
| $247K | ﹤0.01% |
+2,542
| New | +$368K |
|
|
NIU
5156
Niu Technologies
NIU
$156M
| $246K | ﹤0.01% |
47,030
-8,448
| -15% | -$32.5K |
|
5157
CALL
Dell
DELL
$295B
| $245K | ﹤0.01% |
+6,100
| New | +$241K |
|
|
5158
PUT
Dell
DELL
$295B
| $245K | ﹤0.01% |
+6,100
| New | +$241K |
|
|
SBC
5159
SBC Medical Group
SBC
$417M
| $245K | ﹤0.01% |
+24,000
| New | +$243K |
|
|
BGRY
5160
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $245K | ﹤0.01% |
405,036
+227,229
| +128% | +$254K |
|
|
BIOR
5161
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $244K | ﹤0.01% |
7,418
+3,696
| +99% | +$270K |
|
5162
PUT
STAAR Surgical
STAA
$1.11B
| $243K | ﹤0.01% |
+5,000
| New | +$314K |
|
|
ECDA
5163
DELISTED
ECD Automotive Design
ECDA
| $242K | ﹤0.01% |
+121
| New | +$243K |
|
5164
Hingham Institution for Saving
HIFS
$650M
| $242K | ﹤0.01% |
878
-97
| -10% | -$25.6K |
|
5165
Steven Madden
SHOO
$3.24B
| $242K | ﹤0.01% |
7,564
-1,050,481
| -99% | -$32.9M |
|
|
CLYM
5166
Climb Bio
CLYM
$837M
| $242K | ﹤0.01% |
67,685
-4,380
| -6% | -$13K |
|
|
ADAP
5167
DELISTED
Adaptimmune Therapeutics
ADAP
| $240K | ﹤0.01% |
164,659
+153,255
| +1,344% | +$248K |
|
|
AKYA
5168
DELISTED
Akoya BioSciences
AKYA
| $240K | ﹤0.01% |
25,084
-215,149
| -90% | -$2.65M |
|
5169
Levi Strauss
LEVI
$8.19B
| $240K | ﹤0.01% |
15,470
-1,661,896
| -99% | -$25.8M |
|
5170
Latham Group
SWIM
$833M
| $240K | ﹤0.01% |
74,570
-1,077,878
| -94% | -$3.89M |
|
|
AUTL
5171
Autolus Therapeutics
AUTL
$623M
| $239K | ﹤0.01% |
125,650
+46,640
| +59% | +$118K |
|
5172
Landmark Bancorp
LARK
$193M
| $239K | ﹤0.01% |
12,218
-2,336
| -16% | -$48.5K |
|
|
NSTG
5173
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $239K | ﹤0.01% |
+30,000
| New | +$260K |
|
5174
First Northwest Bancorp
FNWB
$108M
| $238K | ﹤0.01% |
15,490
-4,761
| -24% | -$72K |
|
5175
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $238K | ﹤0.01% |
4,782
-1,394
| -23% | -$69K |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.